cGAS/STING signalling in macrophages aggravates obliterative bronchiolitis via an IFN-α-dependent mechanism after orthotopic tracheal transplantation in mice

Abstract

Background: Our previous findings have underscored the role of innate immunity in obliterative bronchiolitis (OB). However, despite the central importance of the cyclic GMP‒AMP synthase (cGAS)/stimulator of interferon genes (STING) signalling pathway in innate immune responses, its specific contribution to OB progression remains largely unexplored.

Methods: A murine orthotopic tracheal transplantation model was established to replicate OB pathogenesis. RNA sequencing and single-cell RNA sequencing data were analysed to investigate mechanisms underlying OB. Key molecules of the cGAS/STING pathway were assessed using immunofluorescence staining. Macrophage-specific Sting1 knockout mice were generated to investigate the role of the cGAS/STING pathway in OB. Haematoxylin and eosin staining and Masson's trichrome staining were utilised to evaluate allograft stenosis and fibrosis. Immune cell infiltration and cytokine expression were analysed using immunofluorescence staining and qRT-PCR. Flow cytometry was used to characterise splenic T-cell subsets and assess co-stimulatory molecule expression in macrophages.

Results: The cGAS/STING pathway was upregulated in macrophages infiltrating allografts. Macrophage-specific Sting1 knockout significantly attenuated alloreactive T-cell responses and alleviated OB. Furthermore, Sting1 deletion reduced the expression of inflammatory marker NOS2, antigen-presenting molecule MHC class II and co-stimulatory molecules (CD80 and CD86) in macrophages. Mechanistically, Sting1 knockout inhibited the production of interferon-α2 (IFN-α2), while the protective effect of macrophage-specific Sting knockout was reversed by IFN-α2 administration. Importantly, STING inhibition enhanced the allograft tolerance-promoting effects of cytotoxic T-lymphocyte-associated antigen 4-Ig (CTLA4-Ig), leading to the preservation of the airway epithelium.

Conclusions: Our study demonstrated that cGAS/STING signalling pathway exacerbated allograft rejection in an IFN-α2-dependent manner. These findings provide insights into potential novel strategies for prolonging allograft survival.

Keywords

cGAS/STING signalling pathway / CTLA4-Ig / obliterative bronchiolitis / type I interferon

References

[1] Lemaître PH, Vokaer B, Charbonnier LM, et al. Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease. Am J Transplant. 2013; 13(3): 611-620.

[2] Van Keymeulen A, Rocha AS, Ousset M, et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature. 2011; 479(7372): 189-193.

[3] Yamada A, Konishi K, Cruz GL, et al. Blocking the CD28-B7 T-cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model. Transplantation. 2000; 69(5): 743-749.

[4] Mirzakhani M, Shahbazi M, Shamdani S, Naserian S, Mohammadnia-Afrouzi M. Innate immunity: trained immunity and innate allorecognition against the allograft. Int Rev Immunol. 2022; 41(2): 275-282.

[5] Ochando J, Fayad ZA, Madsen JC, Netea MG, Mulder WJM. Trained immunity in organ transplantation. Am J Transplant. 2020; 20(1): 10-18.

[6] Xu K-Y, Tong S, Wu C-Y, et al. Nlrp3 inflammasome inhibitor MCC950 ameliorates obliterative bronchiolitis by inhibiting Th1/Th17 response and promoting Treg response after orthotopic tracheal transplantation in mice. Transplantation. 2020; 104(6): e151-e163.

[7] Wan J, Yang F, Tong S, Zhou T, Wang S. Triggering receptor expressed on myeloid cells-1 aggravates obliterative bronchiolitis via enhancing the proinflammatory phenotype of macrophages. Int Immunopharmacol. 2024; 143(pt 1): 113274.

[8] Braza F, Brouard S, Chadban S, Goldstein DR. Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nat Rev Nephrol. 2016; 12(5): 281-290.

[9] Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS‒STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021; 21(9): 548-569.

[10] Fueyo-González F, McGinty M, Ningoo M, et al. Interferon-β acts directly on T cells to prolong allograft survival by enhancing regulatory T cell induction through Foxp3 acetylation. Immunity. 2022; 55(3): 459-474.e7.

[11] Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013; 339(6121): 786-791.

[12] Skopelja-Gardner S, An J, Elkon KB. Role of the cGAS‒STING pathway in systemic and organ-specific diseases. Nat Rev Nephrol. 2022; 18(9): 558-572.

[13] Hu M-M, Shu H-B. Mitochondrial DNA-triggered innate immune response: mechanisms and diseases. Cell Mol Immunol. 2023; 20(12): 1403-1412.

[14] Woo S-R, Fuertes MB, Corrales L, et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014; 41(5): 830-842.

[15] Deng L, Liang H, Xu M, et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity. 2014; 41(5): 843-852.

[16] Lu C, Guan J, Lu S, et al. DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity. Cancer Cell. 2021; 39(1): 96-108.e6.

[17] Bader CS, Jin L, Levy RB. STING and transplantation: can targeting this pathway improve outcomes? Blood. 2021; 137(14): 1871-1878.

[18] Wei C, Huang Q, Zeng F, et al. Cyclic guanosine monophosphate-adenosine monophosphate synthetase/stimulator of interferon genes signaling aggravated corneal allograft rejection through neutrophil extracellular traps. Am J Transplant. 2024; 24(9): 1583-1596.

[19] Wang C, Xia T, Jiang K, et al. Apoptosis of the tracheal epithelium can increase the number of recipient bone marrow-derived myofibroblasts in allografts and exacerbate obliterative bronchiolitis after tracheal transplantation in mice. Transplantation. 2016; 100(9): 1880-1888.

[20] Li Q, Cheng Y, Zhang Z, et al. Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3. Clin Transl Med. 2022; 12(10): e1036.

[21] Konishi H, Okamoto K, Ohmori Y, et al. An orally available, small-molecule interferon inhibits viral replication. Sci Rep. 2012; 2: 259.

[22] Zhang L, DeBerge M, Wang J, et al. Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance. Am J Transplant. 2019; 19(3): 674-685.

[23] Corr M, Boyle DL, Ronacher L, Flores N, Firestein GS. Synergistic benefit in inflammatory arthritis by targeting I kappaB kinase epsilon and interferon beta. Ann Rheum Dis. 2009; 68(2): 257-263.

[24] Liu Y, Wang A, Chen C, et al. Microglial cGAS‒STING signaling underlies glaucoma pathogenesis. Proc Natl Acad Sci U S A. 2024; 121(36): e2409493121.

[25] Sun X, Liu L, Wang J, et al. Targeting STING in dendritic cells alleviates psoriatic inflammation by suppressing IL-17A production. Cell Mol Immunol. 2024; 21(7): 738-751.

[26] Khan MA, Shamma T, Altuhami A, Ahmed HA, Assiri AM, Broering DC. CTLA4-Ig mediated immunosuppression favors immunotolerance and restores graft in mouse airway transplants. Pharmacol Res. 2022; 178: 106147.

[27] Di Campli M-P, Azouz A, Assabban A, et al. The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis. Eur Respir J. 2021; 57(3): 2000344.

[28] Liu H, Yang P, Chen S, et al. Ncf1 knockout in smooth muscle cells exacerbates angiotensin II-induced aortic aneurysm and dissection by activating the STING pathway. Cardiovasc Res. 2024; 120(9): 1081-1096.

[29] Jiang X, Nguyen TT, Tian W, et al. Cyclosporine does not prevent microvascular loss in transplantation but can synergize with a neutrophil elastase inhibitor, Elafin, to maintain graft perfusion during acute rejection. Am J Transplant. 2015; 15(7): 1768-1781.

[30] Baan CC, Kannegieter NM, Felipe CR, Silva HT. Targeting JAK/STAT signaling to prevent rejection after kidney transplantation: a reappraisal. Transplantation. 2016; 100(9): 1833-1839.

[31] Flanagan ME, Blumenkopf TA, Brissette WH, et al. Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection. J Med Chem. 2010; 53(24): 8468-8484.

[32] Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016; 44(3): 450-462.

[33] Zhao Y, Chen S, Lan P, et al. Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model. Am J Transplant. 2018; 18(3): 604-616.

[34] Vincenti F, Rostaing L, Grinyo J, et al. Belatacept and long-term outcomes in kidney transplantation. N Engl J Med. 2016; 374(4): 333-343.

[35] Konishi K, Inobe M, Yamada A, Murakami M, Todo S, Uede T. Combination treatment with FTY720 and CTLA4IgG preserves the respiratory epithelium and prevents obliterative disease in a murine airway model. J Heart Lung Transplant. 2002; 21(6): 692-700.

[36] Zhang X, Bai X-C, Chen ZJ. Structures and mechanisms in the cGAS‒STING innate immunity pathway. Immunity. 2020; 53(1): 43-53.

[37] Hopfner K-P, Hornung V. Molecular mechanisms and cellular functions of cGAS‒STING signalling. Nat Rev Mol Cell Biol. 2020; 21(9): 501-521.

[38] Dvorkin S, Cambier S, Volkman HE, Stetson DB. New frontiers in the cGAS‒STING intracellular DNA-sensing pathway. Immunity. 2024; 57(4): 718-730.

[39] Eaglesham JB, Pan Y, Kupper TS, Kranzusch PJ. Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS‒STING signalling. Nature. 2019; 566(7743): 259-263.

[40] Si W, Liang H, Bugno J, et al. Lactobacillus rhamnosus GG induces cGAS/STING-dependent type I interferon and improves response to immune checkpoint blockade. Gut. 2022; 71(3): 521-533.

[41] Donnelly CR, Jiang C, Andriessen AS, et al. STING controls nociception via type I interferon signalling in sensory neurons. Nature. 2021; 591(7849): 275-280.

[42] Sistigu A, Yamazaki T, Vacchelli E, et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med. 2014; 20(11): 1301-1309.

[43] Zhuang Q, Dai Z, Xu X, et al. RNA methyltransferase FTSJ3 regulates the type I interferon pathway to promote hepatocellular carcinoma immune evasion. Cancer Res. 2024; 84(3): 405-418.

[44] Jungraithmayr W, Jang J-H, Schrepfer S, Inci I, Weder W. Small animal models of experimental obliterative bronchiolitis. Am J Respir Cell Mol Biol. 2013; 48(6): 675-684.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.